Flt3 ligand and conjugation to IL-1β peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine
- 22 May 2002
- Vol. 20 (17-18), 2358-2368
- https://doi.org/10.1016/s0264-410x(02)00096-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Transport of Peptide-MHC Class II Complexes in Developing Dendritic CellsScience, 2000
- Interleukin-1 and Interleukin-1 Fragments as Vaccine AdjuvantsMethods, 1999
- Characterization of Mother-Infant HIV Type 1 gag p17 Sequences Associated with Perinatal TransmissionAIDS Research and Human Retroviruses, 1999
- Bioactive fragment of human interleukin-1 b (163-171) modulates the immune response to synthetic peptides of RESA of Plasmodium falciparumMedical Microbiology and Immunology, 1999
- Cytokine Molecular Adjuvants Modulate Immune Responses Induced by DNA Vaccine Constructs for HIV-1 and SIVJournal of Interferon & Cytokine Research, 1999
- Cross-Clade p17 Peptide Recognition by Antisera to HGP-30, a 30-Amino Acid Synthetic Peptide Antigen from HIV Type 1 p17AIDS Research and Human Retroviruses, 1998
- Random Expression of Human Immunodeficiency Virus-1 (HIV-1) pl7 (Epitopes) on the Surface of the HIV-1-Infected CellHybridoma, 1998
- Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLHInternational Journal of Immunopharmacology, 1991
- Interleukin-1 derived synthetic peptide as an added co-adjuvant in vaccine formulationsVaccine, 1991
- Immune response and epitope mapping of a candidate hiv‐1 p17 vaccine hgp30Journal of Clinical Laboratory Analysis, 1990